Mural Oncology plc Ordinary Shares (MURA) Dividend History

Mural Oncology plc is a biotechnology company focused on developing innovative cancer therapies. The company specializes in research and development initiatives aimed at improving treatment options for oncology patients. It leverages advanced scientific approaches to address unmet medical needs in the cancer treatment landscape.

10 Earlsfort Terrace, Dublin 2, L2, D02 T380
Phone: 353 1 905 8020
Website: https://www.muraloncology.com

Dividend History

Mural Oncology plc Ordinary Shares currently does not pay dividends

Company News

  • Mural Oncology (MURA) Q2 Loss Widens 49%

    Mural Oncology announced the complete discontinuation of all clinical programs, including its lead drug nemvaleukin alfa, and is now exploring strategic alternatives like sale or liquidation after experiencing significant financial losses.

    The Motley Fool
  • Mural Oncology Announces Number of Relevant Securities in Issue

    Mural Oncology, a clinical-stage immuno-oncology company, announces plans to discontinue all clinical development of nemvaleukin following review of data from phase 2 and 3 trials. The company will explore strategic alternatives.

    GlobeNewswire Inc.
  • Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket

    Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results. Applied UV posted a quarterly loss of 32 cents per share, versus a year-ago loss of $1.20 per share. The company’s quarterly sales came in at $11.45 million up from $5.88 million, according to data from Benzinga Pro. Applied UV reaffirmed its previous guidance of approximately $45 million in revenue for 2023. Applied UV shares rose 96.1% to $0.29 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Bruush Oral Care Inc. (NASDAQ: BRSH) shares rose 172.2% to $0.4601 in pre-market trading. Brüush received Nasdaq notification regarding minimum bid requirements. Blue Star Foods Corp. (NASDAQ: BSFC) shares surged 82.2% to $0.2526 in pre-market trading after jumping 18% on Friday. Blue Star Foods recently signed a 2-year bid award purchase agreement with Sysco Corporation. Yoshiharu Global Co. (NASDAQ: YOSH) shares rose 34.2% to $0.47 in pre-market trading. The company recently reported an increase in quarterly sales. MediciNova, Inc. (NASDAQ: MNOV) rose 18% to $2.10 in pre-market trading. The company announced new data and results of a Phase 2 ...

    Benzinga
    Featured Companies: ALGS HITI KRON LGMK MNOV OPTX SGBX SGD THAR WLGS YOSH
Page data last updated 08/19/2025 17:04:13 UTC